Cancer of the gastroesophageal junction: a diagnosis, classification, and management review

Management of gastroesophageal junction (GEJ) adenocarcinoma is a controversial topic. The rising incidence of this cancer requires a clear consensus to ensure proper management. Application of oncological principles for tumors of the esophagus or stomach is not possible because of comparative diffe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chevallay, Mickael (VerfasserIn) , Schmidt, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 August 2018
In: Annals of the New York Academy of Sciences
Year: 2018, Jahrgang: 1434, Pages: 132-138
ISSN:1749-6632
DOI:10.1111/nyas.13954
Online-Zugang:Verlag, Volltext: https://doi.org/10.1111/nyas.13954
Verlag, Volltext: https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/nyas.13954
Volltext
Verfasserangaben:Mickael Chevallay, Elfriede Bollschweiler, Servarayan M. Chandramohan, Thomas Schmidt, Oliver Koch, Giovanni Demanzoni, Stefan Mönig, William Allum
Beschreibung
Zusammenfassung:Management of gastroesophageal junction (GEJ) adenocarcinoma is a controversial topic. The rising incidence of this cancer requires a clear consensus to ensure proper management. Application of oncological principles for tumors of the esophagus or stomach is not possible because of comparative differences in the biology of GEJ adenocarcinoma, leading to different therapeutic options. Staging work-up with endoscopy, endosonography, and PET is essential to inform the choice of neoadjuvant treatment and surgical approach to GEJ adenocarcinoma. Surgery remains the only curative treatment and should be undertaken in specialized centers.
Beschreibung:Gesehen am 25.04.2019
Beschreibung:Online Resource
ISSN:1749-6632
DOI:10.1111/nyas.13954